Biotech Stocks Reviews
- This Compay Is Vital To Gene Therapy Becoming a Commercial Success
Tue, Jul 7
Magenta (MGTA) is pursuing two of the largest challenges in stem cell transplants; mobilizing stem cells · more » - Bellus Data Flop Catches Market By Surprise
Mon, Jul 6
Bellus announced Phase 2 data this morning and it was a major flop. The stock is down 75%. Bellus · more » - Taking Advantage of Fennec’s Rally Ahead of PDUFA
Fri, Jun 26
Fennec is up 50% since announcing their financing on April 30, 2020 @ 6.25/share. During this time, · more » - Market Starting to Realize Potential of Affimed’s Early Pipeline
Tue, Jun 23
Affimed (AFMD) has been on a tear lately as markets are starting to realize the potential of the · more » - Notes from Call With Essa Management
Wed, May 27
We had a call with Essa (EPIX) management earlier today. The initial thesis was that Essa’s · more » - Second Generation Candidate Could Be A Novel Breakthrough in Prostate Cancer
Fri, May 22
Essa Pharma (EPIX) is entering a second-gen drug, with a novel mechanism of action, into clinic for · more » - Milan Study: Giapreza Associated with Oxygen & MAP Improvements
Mon, May 18
Last Friday, San Raffaele Hospital in Milan, Italy, published data using La Jolla’s Giapreza in · more » - Roche Picks Affimed as Its Horse In BCMA Race
Fri, May 15
Affimed Genentech/Roche released their preclinical abstract for an anti-BCMA/CD16a bi-specific · more » - COVID Throws Wrench In AImmune’s Launch Plans
Tue, May 12
Aimmune announced their first quarter of Palforzia launch yesterday and it was greatly impacted by · more »